← All Beyond Air, INC filings

Beyond Air, INC 10-K annual reports

Annual reports — audited financials, the full risk-factor list, and management’s account of the year.

NASDAQ
XAIR
Beyond Air, INC
10-K: Beyond Air FY 2026 Annual Report
Beyond Air reports fiscal year 2026 results, highlighting commercial progress with LungFit PH and ongoing efforts to address going concern risks.
NASDAQ
XAIR
Beyond Air, INC
10-K: Beyond Air Reports Continued Losses Amidst Commercialization Efforts and Pipeline Advancements; Going Concern Doubts Persist
Beyond Air, Inc. reported a net loss of $48.5 million for the fiscal year ended March 31, 2025, with its independent auditors expressing substantial doubt about the company's ability to continue as a going concern despite increased revenue from its LungFit PH system and ongoing capital raising efforts.
NASDAQ
XAIR
Beyond Air, INC
10-K: Beyond Air, Inc. Navigates Growth with Focus on LungFit Platform and Novel Therapies
Beyond Air, Inc. is advancing its LungFit platform and exploring novel therapies for respiratory, oncological, and neurological conditions, as detailed in its recent annual report.